Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
Monday, July 20, 2026 1 min read
Key Takeaway: Arcturus Therapeutics Holdings Inc. has announced its participation in the Canaccord Genuity 46th Annual Growth Conference. The event will take place on August 11, 2026, in Boston, Massachusetts, where the company will engage in a fireside chat. This presentation underscores Arcturus's commitment to advancing its messenger RNA therapeutics.
Price reaction · baseline $5.97 (2026-07-20 close) · hit after-hours · clean, no other ARCT news in the window
day 0 close
+0.3%
Market Sentiment Analysis
POSITIVE FACTORS
Arcturus Therapeutics is actively engaging with investors.
The company is focused on innovative messenger RNA medicines.
Participation in a notable investor conference highlights its growth potential.
Full Press Release Details
SAN DIEGO--(BUSINESS WIRE)---- $ARCT #65Roses--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced that the Company will present at the following investor conference in Boston, Massachusetts: Canaccord Genuity 46th Annual Growth Conference (Fireside Chat) Tuesday, August 11, 2026 (12:00 p.m. ET) Webcast link can be found under Investor Relations/Events section
Frequently Asked Questions
When will Arcturus present at the conference?
Arcturus will present at the Canaccord Genuity conference on August 11, 2026.
Where is the Canaccord Genuity conference held?
The conference will take place in Boston, Massachusetts.
What type of company is Arcturus Therapeutics?
Arcturus is focused on developing messenger RNA medicines for rare diseases.
What is the format of Arcturus's presentation?
Arcturus will participate in a fireside chat during the conference.